Grantham, Mayo, Van Otterloo & Co (GMO)
EVHC

Grantham, Mayo, Van Otterloo & Co (GMO)’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EVHC Stock Details EVHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-61,024
Closed -$3.74M – 654
2017
Q1 		$3.74M Hold
61,024
– – 0.02% 265
2016
Q4 		$3.86M Sell
61,024
-750,262
-92% -$49M 0.02% 260
2016
Q3 		$54.1M Buy
+811,286
New +$55.9M 0.26% 101

Other funds holding EVHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $743M AUM 34.03% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EVHC Position: Q2 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Envision Healthcare Holdings Inc (EVHC) in Q2 2017, closing a stake of 61,024 shares — an estimated $3.74M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EVHC in Q3 2016 and held it in 3 quarters. The position peaked at $54.1M in Q3 2016. 374 funds tracked by Wall St. Rank hold EVHC as of Q2 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Envision Healthcare Holdings Inc position as of Q2 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 61,024 Envision Healthcare Holdings Inc shares in Q2 2017, an estimated $3.74M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Envision Healthcare Holdings Inc in Q3 2016 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Envision Healthcare Holdings Inc position peaked at $54.1M in Q3 2016.
  • 374 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q2 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2017, filed 14 Aug 2017.